Condition
Relapsed/Refractory B-cell Non-Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Relapsed/Refractory B-cell Non-Hodgkin Lymphoma clinical trials that are recruiting, at sites in 2 countries (most in China (2), Malaysia (1)). By phase: Phase 2 (1), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Relapsed/Refractory B-cell Non-Hodgkin Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| IMV101 for relapsed or refractory CD19-positive B‑cell non‑Hodgkin lymphoma | Early Phase 1 | Beijing, Beijing Municipality and 3 other locations | Recruiting | Jan 29, 2026 |
| IBR900 cell injection for relapsed or refractory CD20-positive B-cell non-Hodgkin lymphoma | Phase 1 | Hangzhou, Zhejiang and 1 other locations | Recruiting | Jul 18, 2025 |
| Evaluating CAR-T Cell Therapy for Relapsed B-Cell Lymphoma | Phase 2 | Bandar Tun Razak, Kuala Lumpur | Recruiting | Nov 21, 2024 |
All recruiting trials (3)
-
IMV101 for relapsed or refractory CD19-positive B‑cell non‑Hodgkin lymphoma
This trial tests IMV101 to see if it is safe and can shrink tumors in adults with relapsed or refractory CD19‑positive B‑cell non‑Hodgkin lymphoma who have had multiple prior treatments.
-
IBR900 cell injection for relapsed or refractory CD20-positive B-cell non-Hodgkin lymphoma
This study will test whether IBR900 cell injections, given alone or with rituximab, are safe and can help adults with relapsed or refractory CD20-positive B-cell non-Hodgkin lymphoma.
-
Evaluating CAR-T Cell Therapy for Relapsed B-Cell Lymphoma
This study is testing a new CAR-T cell therapy to see if it can help people with relapsed B-cell lymphoma who haven't responded to other treatments and can't have a stem cell transplant.
Quick answers
How many Relapsed/Refractory B-cell Non-Hodgkin Lymphoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), Malaysia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.